HRT FINANCIAL LP

Position in AMGN — Amgen Inc

CIK 1475597 NEW YORK, NY

Position in AMGN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$113,195,422

+$104,299,735 QoQ

Shares Held

321,715

+1026.7% QoQ

Ownership

0.060%

of shares outstanding

% of Portfolio

0.49%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $579,743,845 across 13 Drug Manufacturers - General names. AMGN ranks #3 (19.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	926,410	$201,484,910
2	BMY	Bristol Myers Squibb Co	2,075,945	$125,906,064
3	AMGN	Amgen Inc This page	321,715	$113,195,422
4	LLY	ELI LILLY & Co	53,051	$48,794,718
5	GILD	Gilead Sciences, Inc.	270,699	$37,727,319
6	GSK	GSK plc	425,687	$23,493,665
7	MRK	Merck & Co., Inc.	142,729	$17,168,871
8	NVS	Novartis AG	24,886	$3,801,336

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$113,195,422	321,715	+1026.7%	Shares	Defined	2026-05-14
2025-03-31	$8,895,687	28,553	+112.5%	Shares	Defined	2025-05-15
2024-06-30	$4,199,015	13,439	-59.5%	Shares	Defined	2024-08-12
2023-12-31	$9,551,895	33,164	+104.0%	Shares	Defined	2024-02-09
2023-06-30	$3,608,935	16,255	-88.3%	Shares	Defined	2023-08-11
2022-12-31	$36,451,542	138,789	-68.5%	Shares	Defined	2023-02-10
2022-06-30	$107,170,730	440,488	+1079.0%	Shares	Defined	2022-08-12
2022-03-31	$9,034,637	37,361	-46.4%	Shares	Defined	2022-05-16
2021-12-31	$15,675,459	69,678	+60.8%	Shares	Defined	2022-02-14
2021-09-30	$9,217,314	43,345	-58.2%	Shares	Defined	2021-11-15
2021-06-30	$25,246,406	103,575	+956.3%	Shares	Defined	2021-08-16
2020-03-31	$1,987,767	9,805	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.